Total Revenues of Rs. 1,531 million up by 16.2%, EBITDA of Rs. 312 million with margins of 20.4% Performance backed…
India operations revenue up by 84% to Rs. 550 Crs. and EBITDA up by 460% to Rs. 71 Crs. Y-o-Y …
New Delhi, August 13, 2021: J. B. Chemicals & Pharmaceuticals Limited (JBCPL), one of the fastest growing pharmaceutical companies in…
Becomes a Zero net-debt company paying its outstanding debt to the Financial Institution Net revenues in Q1FY21 at Rs. 103.01…
Sales down only slightly year-on-year at EUR 1.704 billion EBITDA pre exceptionals falls by 9.9 percent to EUR 245 million EBITDA margin…
Hyderabad, January27, 2020: Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE:DRREDDY | NYSE: RDY) today announced its consolidated financial results…
Aggregate revenues of companies in sample set grew by a healthy ~14% on a Y-o-Y basis in Q2 FY2020 over…
Revenue up 24.6% Y-o-Y to INR 5,827.4 Mn, Operating EBITDA at INR 1,095.5 Mn Chennai, August 10, 2019: TAKE Solutions…
Consolidated Revenue stable at Rs. 84.1 cr in Q1 FY20 as against Rs. 83.5 cr in Q1 FY19 despite maintenance…
Revenue at Rs. 2,182 Crore up 5% YoY; EBITDA at Rs 444 Crores down 1% YoY PAT at Rs 185…